In the latest trading session,, 0.64 million Repligen Corp (NASDAQ:RGEN) shares changed hands as the company’s beta touched 1.19. With the company’s most recent per share price at $135.50 changed hands at -$8.13 or -5.66% at last look, the market valuation stands at $7.61B. RGEN’s current price is a discount, trading about -34.7% off its 52-week high of $182.52. The share price had its 52-week low at $102.96, which suggests the last value was 24.01% up since then. When we look at Repligen Corp’s average trading volume, we note the 10-day average is 0.78 million shares, with the 3-month average coming to 771.54K.
Analysts gave the Repligen Corp (RGEN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.70. If we narrow down to specifics, the data shows that 1 out of 9 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended RGEN as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Repligen Corp’s EPS for the current quarter is expected to be 0.41.
Repligen Corp (NASDAQ:RGEN) trade information
Instantly RGEN was in red as seen in intraday trades today. With action -2.47%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -5.86%, with the 5-day performance at -2.47% in the red. However, in the 30-day time frame, Repligen Corp (NASDAQ:RGEN) is 1.57% up. Looking at the short shares, we see there were 3.24 million shares sold at short interest cover period of 3.61 days.
The consensus price target for the stock as assigned by Wall Street analysts is 220, meaning bulls need an upside of 38.41% from its recent market value. According to analyst projections, RGEN’s forecast low is 220 with 220 as the target high. To hit the forecast high, the stock’s price needs a -62.36% plunge from its current level, while the stock would need to soar -62.36% for it to hit the projected low.
Repligen Corp (RGEN) estimates and forecasts
Year-over-year growth is forecast to reach 10.46% up from the last financial year.
Consensus estimates given by 16 financial analysts project the company’s revenue in the current quarter to hit an average of 173.18M. 16 analysts are of the opinion that Repligen Corp’s revenue for the current quarter will be 173.57M. The company’s revenue for the corresponding quarters a year ago was 154.07M and 154.87M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 12.40%. The estimates for the next quarter sales put growth at 12.08%.
The 2025 estimates are for Repligen Corp earnings to increase by 7.84%, but the outlook for the next 5-year period is at 21.44% per year.
RGEN Dividends
Repligen Corp is expected to release its next quarterly earnings report on 2025-Feb-19.
Repligen Corp (NASDAQ:RGEN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.44% of Repligen Corp shares while 103.77% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 110.91%. There are 103.77% institutions holding the Repligen Corp stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 13.5432% of the shares, roughly 7.57 million RGEN shares worth $954.08 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.0659% or 5.07 million shares worth $638.67 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 1.7 shares estimated at $229.63 million under it, the former controlled 3.03% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.97% of the shares, roughly 1.67 shares worth around $225.19 million.
